Granules Pharmaceuticals Recalls

2 recalls found for Granules Pharmaceuticals. Check if any of your products are affected.

HIGHFDA DRUG

Granules Pharmaceuticals Recalls Amphetamine Capsules Over Impurity Risks

Granules Pharmaceuticals recalled 11,928 bottles of amphetamine capsules on August 28, 2025. The recall follows failure to meet impurities and degradation specifications. Consumers should stop using the product immediately and contact their healthcare providers.

Granules Pharmaceuticals
Failed Impurities/Degradation
Read more
HIGHFDA DRUG

Granules Pharmaceuticals Recalls Dextroamphetamine Capsules Over Contamination Risk

Granules Pharmaceuticals Inc. recalled 9,917 bottles of Dextroamphetamine extended-release capsules on August 28, 2025. The product failed impurities and degradation specifications, posing potential health risks. Consumers should stop using the capsules immediately and consult healthcare providers for guidance.

Granules Pharmaceuticals
Failed Impurities/Degradation
Read more

Brand Statistics

Total Recalls
2
Pages
1